20128808

Source:http://linkedlifedata.com/resource/pubmed/id/20128808

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0034705, umls-concept:C0205198, umls-concept:C0234421, umls-concept:C0243192, umls-concept:C0390423, umls-concept:C1280500, umls-concept:C1948023
pubmed:issue	3
pubmed:dateCreated	2010-4-12
pubmed:abstractText	Angiotensin type 2 receptor (AT(2) receptor) stimulation evokes vasodilator effects in vitro and in vivo that oppose the vasoconstrictor effects of angiotensin type 1 receptors (AT(1) receptors). Recently, a novel non-peptide AT(2) receptor agonist, Compound 21, was described, which exhibited high AT(2) receptor selectivity.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/20128808-10510333, http://linkedlifedata.com/resource/pubmed/commentcorrection/20128808-10523343, http://linkedlifedata.com/resource/pubmed/commentcorrection/20128808-10567191, http://linkedlifedata.com/resource/pubmed/commentcorrection/20128808-10821779, http://linkedlifedata.com/resource/pubmed/commentcorrection/20128808-10977869, http://linkedlifedata.com/resource/pubmed/commentcorrection/20128808-11171796, http://linkedlifedata.com/resource/pubmed/commentcorrection/20128808-11230289, http://linkedlifedata.com/resource/pubmed/commentcorrection/20128808-11711513, http://linkedlifedata.com/resource/pubmed/commentcorrection/20128808-11751702, http://linkedlifedata.com/resource/pubmed/commentcorrection/20128808-12364356, http://linkedlifedata.com/resource/pubmed/commentcorrection/20128808-14530223, http://linkedlifedata.com/resource/pubmed/commentcorrection/20128808-14610239, http://linkedlifedata.com/resource/pubmed/commentcorrection/20128808-14998339, http://linkedlifedata.com/resource/pubmed/commentcorrection/20128808-15197103, http://linkedlifedata.com/resource/pubmed/commentcorrection/20128808-15537354, http://linkedlifedata.com/resource/pubmed/commentcorrection/20128808-15586018, http://linkedlifedata.com/resource/pubmed/commentcorrection/20128808-15710752, http://linkedlifedata.com/resource/pubmed/commentcorrection/20128808-15767466, http://linkedlifedata.com/resource/pubmed/commentcorrection/20128808-15831358, http://linkedlifedata.com/resource/pubmed/commentcorrection/20128808-15834290, http://linkedlifedata.com/resource/pubmed/commentcorrection/20128808-17159079, http://linkedlifedata.com/resource/pubmed/commentcorrection/20128808-18307726, http://linkedlifedata.com/resource/pubmed/commentcorrection/20128808-18347570, http://linkedlifedata.com/resource/pubmed/commentcorrection/20128808-18804122, http://linkedlifedata.com/resource/pubmed/commentcorrection/20128808-19029468, http://linkedlifedata.com/resource/pubmed/commentcorrection/20128808-7477266, http://linkedlifedata.com/resource/pubmed/commentcorrection/20128808-9453327
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7502536
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Benzimidazoles, http://linkedlifedata.com/resource/pubmed/chemical/Imidazoles, http://linkedlifedata.com/resource/pubmed/chemical/PD 123319, http://linkedlifedata.com/resource/pubmed/chemical/Peptides, http://linkedlifedata.com/resource/pubmed/chemical/Pyridines, http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Angiotensin, Type 1, http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Angiotensin, Type 2, http://linkedlifedata.com/resource/pubmed/chemical/Tetrazoles, http://linkedlifedata.com/resource/pubmed/chemical/Vasoconstrictor Agents, http://linkedlifedata.com/resource/pubmed/chemical/Vasodilator Agents, http://linkedlifedata.com/resource/pubmed/chemical/candesartan
pubmed:status	MEDLINE
pubmed:month	Feb
pubmed:issn	1476-5381
pubmed:author	pubmed-author:AltermanMM, pubmed-author:BosnyakSS, pubmed-author:HallbergAA, pubmed-author:JonesE SES, pubmed-author:WelungodaI KIK, pubmed-author:WiddopR ERE
pubmed:issnType	Electronic
pubmed:day	1
pubmed:volume	159
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	709-16
pubmed:dateRevised	2011-7-22
pubmed:meshHeading	pubmed-meshheading:20128808-Animals, pubmed-meshheading:20128808-Aorta, pubmed-meshheading:20128808-Benzimidazoles, pubmed-meshheading:20128808-Blood Pressure, pubmed-meshheading:20128808-Blood Vessels, pubmed-meshheading:20128808-Cardiovascular System, pubmed-meshheading:20128808-Consciousness, pubmed-meshheading:20128808-Imidazoles, pubmed-meshheading:20128808-Male, pubmed-meshheading:20128808-Mice, pubmed-meshheading:20128808-Mice, Inbred Strains, pubmed-meshheading:20128808-Peptides, pubmed-meshheading:20128808-Pyridines, pubmed-meshheading:20128808-Rats, pubmed-meshheading:20128808-Rats, Inbred SHR, pubmed-meshheading:20128808-Rats, Inbred WKY, pubmed-meshheading:20128808-Receptor, Angiotensin, Type 1, pubmed-meshheading:20128808-Receptor, Angiotensin, Type 2, pubmed-meshheading:20128808-Tetrazoles, pubmed-meshheading:20128808-Vasoconstrictor Agents, pubmed-meshheading:20128808-Vasodilation, pubmed-meshheading:20128808-Vasodilator Agents
pubmed:year	2010
pubmed:articleTitle	Stimulation of angiotensin AT2 receptors by the non-peptide agonist, Compound 21, evokes vasodepressor effects in conscious spontaneously hypertensive rats.
pubmed:affiliation	Department of Pharmacology, Monash University, Clayton, Vic., Australia.
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't